Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of CLDN1 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of CLDN1 mRNA | affects expression | 21346803
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of CLDN1 mRNA | increases expression | 18648102
|
C075773 |
4-phenylbutyric acid |
4-phenylbutyric acid results in decreased expression of CLDN1 mRNA | decreases expression | 14583596
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of CLDN1 mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CLDN1 mRNA | affects expression | 16483693
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of CLDN1 mRNA | increases expression | 18687144
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CLDN1 mRNA | affects cotreatment|decreases expression | 18164116
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of CLDN1 mRNA | decreases expression | 20106945
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of CLDN1 mRNA | affects expression | 20382639
|
D002995 |
Clofibric Acid |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CLDN1 mRNA | affects cotreatment|affects expression | 17602206
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of CLDN1 mRNA | increases expression | 18042831
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CLDN1 mRNA | affects cotreatment|decreases expression | 18164116
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CLDN1 mRNA | affects cotreatment|affects expression | 17602206
|
D002117 |
Calcitriol |
Calcitriol results in decreased expression of CLDN1 mRNA | decreases expression | 16002434
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of CLDN1 mRNA | decreases expression | 16404146
|
D019833 |
Genistein |
Genistein results in increased expression of CLDN1 mRNA | increases expression | 18847459
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide affects the expression of CLDN1 mRNA | affects expression | 18661270
|
D015735 |
Mifepristone |
Mifepristone inhibits the reaction [Progesterone results in decreased expression of CLDN1 protein] | decreases expression|decreases reaction | 17478549
|
D009151 |
Mustard Gas |
Mustard Gas results in decreased expression of CLDN1 mRNA | decreases expression | 18988085
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in increased expression of CLDN1 mRNA | increases expression | 17616710
|
C041786 |
palm oil |
palm oil results in increased expression of CLDN1 mRNA | increases expression | 18042831
|
D010634 |
Phenobarbital |
Phenobarbital results in decreased expression of CLDN1 mRNA | decreases expression | 19270015
|
D019800 |
Phenol |
Phenol affects the localization of CLDN1 protein | affects localization | 19679145
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CLDN1 mRNA | affects binding|decreases expression|increases activity | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of CLDN1 mRNA | decreases expression | 18445702
|
D011374 |
Progesterone |
Mifepristone inhibits the reaction [Progesterone results in decreased expression of CLDN1 protein] | decreases expression|decreases reaction | 17478549
|
D011374 |
Progesterone |
Progesterone results in decreased expression of CLDN1 protein | decreases expression | 17478549
|
C045950 |
propiconazole |
propiconazole results in decreased expression of CLDN1 mRNA | decreases expression | 19423681
|
C059514 |
resveratrol |
resveratrol results in increased expression of CLDN1 mRNA | increases expression | 17257620
|
C446685 |
systhane |
systhane results in decreased expression of CLDN1 mRNA | decreases expression | 19423681
|
C517826 |
tetrabrominated diphenyl ether 47 |
tetrabrominated diphenyl ether 47 results in increased expression of CLDN1 mRNA | increases expression | 20056577
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of CLDN1 mRNA | increases expression | 17035482
|
C496197 |
trans-10,cis-12-conjugated linoleic acid |
trans-10,cis-12-conjugated linoleic acid results in decreased expression of CLDN1 mRNA | decreases expression | 16650747
|
D014212 |
Tretinoin |
CYP26A1 protein inhibits the reaction [Tretinoin results in increased expression of CLDN1 mRNA] | decreases reaction|increases expression | 17035595
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of CLDN1 mRNA | increases expression | 17035595
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of CLDN1 protein | increases expression | 17035595
|
C032910 |
triadimefon |
triadimefon results in decreased expression of CLDN1 mRNA | decreases expression | 19423681
|
C034028 |
vanadyl sulfate |
vanadyl sulfate results in increased expression of CLDN1 mRNA | increases expression | 16330358
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
7.17 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.17 | 14514962 11752688 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.22 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.55 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.81 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
6.60 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
6.60 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
6.60 | 11473722 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
18.91 | 3712494 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
18.91 | 6695378 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
18.91 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
18.91 | 6695378 10737359 |
MESH:D000236 |
Adenoma |
|
resveratrol |
18.91 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
22.05 | 19061943 17162532 17620307 16434500 18056438 19052882 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
22.05 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
22.05 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
22.05 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.22 | 21441931 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.35 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.49 | 16162502 16183991 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.65 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.50 | 10982225 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.74 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.56 | 15238619 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
6.81 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
6.81 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.18 | 16292516 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
4.61 | 10378619 |
MESH:D001249 |
Asthma |
|
Tretinoin |
4.61 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.07 | 16873680 17967414 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.36 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
tetrabrominated diphenyl ether 47 |
2.36 | 19211157 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.08 | 16935849 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.67 | 1440618 11289319 |
MESH:D001768 |
Blister |
|
Mustard Gas |
4.82 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
13.51 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
13.51 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
13.51 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.44 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.55 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.35 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
Phenol |
4.89 | 10556009 |
MESH:D001913 |
Bowen's Disease |
|
Phenol |
5.41 | 19293009 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.99 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
3.93 | 15845082 15665606 15380490 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
3.94 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.52 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 19579870 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
6.60 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
6.60 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
6.60 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
6.60 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
6.60 | 16096432 16595493 18628466 16935488 16264153 17426702 15939500 17983394 18695136 15634643 15994142 15668708 15993339 16322301 18382427 19526202 15692762 18234424 16826403 11325840 15136595 17369602 16115903 15567936 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
6.60 | 16873071 16541309 17200150 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
6.60 | 17614352 15562024 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
6.60 | 17534123 17651959 16393696 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
6.60 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
6.60 | 16443354 16166294 16873071 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
4.82 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
4.63 | 10378619 17687719 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.25 | 16813970 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.46 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.53 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.81 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
21.63 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
21.63 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
21.63 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
21.63 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
21.63 | 20514400 19418558 19701751 16698587 19208518 16878318 16328049 18978308 16502159 16681979 19052882 19107877 18393292 19394651 18210153 10737359 16569478 18788625 20727157 18056438 3084413 19519916 10672840 20432363 20214788 17055752 16935385 20084675 19539802 18665156 20007298 3581430 17978847 19383236 17761372 18971187 21159647 16807293 19822196 16540662 11831363 19919837 18506893 20101231 19171122 18785209 17138121 17162532 20524982 18691550 16779866 20935162 17173139 19335982 16288022 18494052 17428255 16830150 20512989 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
21.63 | 16234567 17876044 18059187 16023760 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
21.63 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
21.63 | 20007298 1701930 17173139 20935162 6705139 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
21.63 | 16227395 19321006 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
21.63 | 1917145 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.25 | 16675471 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
6.00 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
6.00 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
13.19 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
13.19 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
13.19 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
13.19 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
13.19 | 16096774 16051514 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.18 | 16120746 18670907 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.31 | 16455267 17974986 15792986 15505089 17928571 16109756 17924179 17519947 16242529 15476868 16952015 16269455 16278810 16651473 15811867 17382496 16612575 18627295 17007740 17351982 17329180 16731534 16364871 17308081 17131338 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.83 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
10.90 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
10.90 | 16936243 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
10.90 | 15458977 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
6.56 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
6.56 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
14.10 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
14.10 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
14.10 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
14.10 | 17174075 7505956 2727394 21159647 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
3.92 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.25 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.38 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.38 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
7.01 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.01 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.81 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
9.06 | 15668235 8697196 12621046 15340226 16354765 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
9.06 | 9407595 |
MESH:D002972 |
Cleft Palate |
|
triadimefon |
9.06 | 16781842 |
MESH:D003092 |
Colitis |
|
resveratrol |
8.52 | 16474422 |
MESH:D003092 |
Colitis |
|
Tretinoin |
8.52 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
3.70 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
3.70 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.64 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.64 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.78 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.53 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.66 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.66 | 14991402 10589399 8800419 17551590 9125849 16925845 9211117 9142499 9224671 9664655 |
MESH:D019465 |
Craniofacial Abnormalities |
|
triadimefon |
3.66 | 15834900 16875885 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
9.79 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
9.79 | 18551238 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.49 | 11906362 18759878 14531868 11298694 2524372 8970840 12868966 8156756 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.27 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.18 | 2952479 3621924 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
7.88 | 16873680 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
vanadyl sulfate |
7.88 | 16684804 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
6.56 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
6.56 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.56 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
3.68 | 16286809 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.16 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
16.99 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
16.99 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
16.99 | 18289764 1440618 18692083 9328219 9022650 6482804 8291058 6679447 16192314 18648102 7440962 11289319 9653073 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
16.99 | 19420014 16081117 17522070 19739265 12958197 11461765 11834606 15968718 12392966 19085960 14986274 16177239 16227642 11287661 10774834 19416960 15619225 16781746 11421492 14725611 12540782 10915739 11739529 16109766 11529661 12705907 16393943 18071297 2444490 17906064 10663392 19923254 17562736 12594235 19370779 11743745 18713872 16485898 14550746 12153990 19164858 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
16.99 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
16.99 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
16.99 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.75 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.28 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.28 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.21 | 18367378 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.69 | 1851702 |
MESH:D004487 |
Edema |
|
Mustard Gas |
13.97 | 11428647 9260866 11402378 11428631 |
MESH:D004487 |
Edema |
|
pirinixic acid |
13.97 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
13.97 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
13.97 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
10.79 | 15322242 18230668 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
10.79 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
13.62 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
13.62 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
13.62 | 17872969 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.25 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
11.24 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
11.24 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
11.24 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Mifepristone |
13.63 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
13.63 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
13.63 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.81 | 18037988 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.52 | 17923197 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.78 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.53 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.71 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.26 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
3.92 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.68 | 3659116 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
4.82 | 9357497 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.77 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
9.60 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
9.60 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
9.60 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
9.60 | 16704527 15878914 15547721 16510608 15150132 15264214 15623463 15547733 16805852 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.00 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.00 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
11.35 | 19551842 19004024 17967931 18296743 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
11.35 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
11.35 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.12 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.67 | 6705139 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.25 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
12.85 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
12.85 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
12.85 | 17994277 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.33 | 16983495 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
10.64 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
10.64 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
10.64 | 17312396 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.72 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.25 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
7.08 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.08 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.81 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.03 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.03 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
10.03 | 14991402 9664655 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.25 | 16495754 18674790 16244372 16879835 17875725 16144979 18006777 14766674 16707910 16330681 16244371 17888722 12587719 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
6.35 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.35 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.60 | 15692506 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.03 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.19 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
29.45 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
29.45 | 19772884 16221962 19176532 18467677 |
MESH:D006529 |
Hepatomegaly |
|
propiconazole |
29.45 | 17178689 17178688 |
MESH:D006529 |
Hepatomegaly |
|
systhane |
29.45 | 17178689 17178688 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
29.45 | 15340226 12621046 16120746 |
MESH:D006529 |
Hepatomegaly |
|
triadimefon |
29.45 | 17178688 17178689 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.84 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.13 | 17606976 18501091 15147373 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.70 | 8697196 18606429 15340226 16354765 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
6.74 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
6.74 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
8.21 | 21332399 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
8.21 | 17188708 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.24 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.89 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
8.25 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
8.25 | 16873680 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.61 | 15034207 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.78 | 18850075 18670907 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.01 | 17488730 |
OMIM:607626 |
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS |
marker/mechanism |
|
| |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
10.38 | 15869954 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
10.38 | 17600658 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
17.61 | 20412841 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
17.61 | 18785209 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
17.61 | 8975870 9357497 17524151 11428631 16001271 9260866 11402378 11428620 11428647 |
MESH:D007249 |
Inflammation |
|
Progesterone |
17.61 | 15869954 |
MESH:D007249 |
Inflammation |
|
resveratrol |
17.61 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
17.61 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.20 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
6.51 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.51 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.44 | 17994277 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.67 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
15.50 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
15.50 | 15992940 17551590 |
MESH:D007569 |
Jaw Abnormalities |
|
triadimefon |
15.50 | 15992940 15834900 |
MESH:D055623 |
Keratosis, Actinic |
|
Phenol |
6.10 | 19293009 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.40 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
5.40 | 15369732 16775033 15699352 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
9.12 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
9.12 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
10.81 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
10.81 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
10.81 | 6582329 |
MESH:D007938 |
Leukemia |
|
Genistein |
5.83 | 18980019 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
5.83 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.81 | 16085563 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.40 | 19285840 16932348 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.02 | 16294345 17596541 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
7.03 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
7.03 | 9834237 12679006 16140955 17506722 17712046 15748426 16823087 17301526 17361223 16766008 19642359 17368321 19225113 17217047 16891316 19029980 16788101 16331271 17339181 17107899 19075265 19035177 17294898 16935935 17649720 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.07 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
9.92 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
9.92 | 19638242 20032147 18407596 18522880 18665156 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
9.92 | 21047994 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
2.98 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
6.22 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
6.22 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.22 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.22 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
6.22 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
11.52 | 16610002 12969438 16611625 19460945 19784758 12587719 19014921 11587558 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
11.52 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
11.52 | 19363144 |
MESH:D008107 |
Liver Diseases |
|
propiconazole |
11.52 | 19363144 |
MESH:D008107 |
Liver Diseases |
|
triadimefon |
11.52 | 19363144 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
2.94 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
35.65 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
35.65 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
35.65 | 19389873 21295105 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
35.65 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
35.65 | 19812893 21071580 15175105 19551842 19254457 2422723 20101389 21167192 19690152 20118626 18648771 18978307 18754104 9163691 20452335 20405173 19426721 19833225 18644402 19256749 18977376 2862719 19294768 21047994 19427195 20434301 19638242 10737359 16942905 19642983 19499222 19255062 12771043 19090486 19073162 20492335 12112319 20501860 21278145 19996281 20137499 15885732 19850985 20583210 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
35.65 | 19482888 19073162 21047994 8742319 19812893 15975961 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
35.65 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
propiconazole |
35.65 | 19028983 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
35.65 | 19073162 19812893 20405173 19321006 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
35.65 | 16984957 |
MESH:D008113 |
Liver Neoplasms |
|
triadimefon |
35.65 | 19028983 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
39.13 | 2876786 6135515 2876784 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
39.13 | 6587162 598648 3712494 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
39.13 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
39.13 | 21159647 18544905 19004024 18079962 9362446 18253720 18282651 19126423 17854601 18775883 19539802 18164116 19009564 3124819 19519916 18308698 17174075 16842330 17942915 18093689 16267830 2563599 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
39.13 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
39.13 | 1399818 2563599 17172636 18308698 6150874 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
propiconazole |
39.13 | 17178689 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
systhane |
39.13 | 17178689 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
39.13 | 12151625 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
triadimefon |
39.13 | 17178689 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
3.22 | 18161513 18702808 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
3.69 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
6.09 | 18569708 20869020 20135361 18520028 18816296 20064080 6695378 17053015 20464547 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
6.09 | 21163286 20970405 20512841 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
6.09 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
6.09 | 3148597 8781369 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.09 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.22 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
3.99 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
7.97 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
7.97 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.23 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
3.91 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
12.52 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
12.52 | 12929590 14578162 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
12.52 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
12.52 | 8985016 11606380 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.65 | 17453147 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
4.80 | 16827129 |
MESH:D008545 |
Melanoma |
|
resveratrol |
4.80 | 17992120 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
4.80 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.24 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.09 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
5.96 | 18303189 16166281 16966607 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
5.96 | 17638057 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.07 | 17112576 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.19 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.93 | 16381670 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.45 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.23 | 16267019 16490592 17935668 17049120 14749477 17164350 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.53 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.17 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
2.88 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
12.36 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
12.36 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
12.36 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
12.36 | 16525036 16317513 17188708 17125593 16456233 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
8.12 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.12 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
7.53 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.53 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.42 | 17322642 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.13 | 17484760 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
9.21 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
9.21 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
8.69 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
8.69 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
8.69 | 18259882 |
MESH:D009369 |
Neoplasms |
|
4-phenylbutyric acid |
10.47 | 19116145 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
10.47 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
10.47 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
10.47 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
3.67 | 8985016 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.44 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.72 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
14.51 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
14.51 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
14.51 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
6.49 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
6.49 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.09 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
12.46 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
12.46 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
12.46 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.09 | 17929310 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.77 | 20387270 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
3.66 | 16761898 7688884 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.13 | 19632207 21332399 20518802 18457598 17217161 11836018 16723640 20132043 18674790 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.13 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
13.37 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
13.37 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
13.37 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.67 | 3988306 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.02 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.04 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
9.11 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
9.11 | 17513867 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.85 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
10.40 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Mifepristone |
10.40 | 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
10.40 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
10.40 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
9.79 | 16870215 |
MESH:D010146 |
Pain |
|
Phenol |
9.79 | 17610455 |
MESH:D010146 |
Pain |
|
Tretinoin |
9.79 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
7.85 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
7.85 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
7.85 | 15976015 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
8.21 | 7296757 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
8.21 | 12065085 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.90 | 12520081 |
MESH:D010392 |
Pemphigus |
|
Phenol |
6.10 | 17163923 16522979 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.12 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.81 | 17983394 |
MESH:D010864 |
Pilonidal Sinus |
|
Phenol |
6.10 | 15622588 19655223 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.56 | 10923243 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.81 | 17638057 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
8.12 | 15727166 |
MESH:D011041 |
Poisoning |
|
Phenol |
8.12 | 8825745 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.24 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
8.15 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
8.15 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
8.46 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.46 | 11222880 11118676 11896295 11399792 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.44 | 15572423 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.90 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
1.90 | 15754350 18247401 16644109 16289102 12479363 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
1.90 | 16888761 16729912 15749863 15897917 16868541 18437689 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
1.90 | 16925846 15378649 15256057 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
1.90 | 15767336 17675339 16731767 17636462 17718901 17804756 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.29 | 16636307 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
3.75 | 18058305 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.15 | 12752131 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.45 | 16723453 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
5.46 | 17975199 17365031 15814490 17322281 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
5.46 | 17266442 10334151 17620002 17894541 17720292 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
3.89 | 17922066 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.24 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
6.00 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
6.00 | 15827377 16314181 17520802 16317513 17058453 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.51 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.12 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.79 | 16116481 16283617 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.73 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.70 | 15625365 18313854 16767912 15675481 17710206 17203757 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
3.92 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.45 | 17846226 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
8.47 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
8.47 | 18551238 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
8.47 | 11442880 4039156 3137016 16876388 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.48 | 6407741 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
2.62 | 16961503 12880345 15451306 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
20.34 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
20.34 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
20.34 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
20.34 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
20.34 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
20.34 | 16467112 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.23 | 15625365 17203757 16767912 |
MESH:D013088 |
Spermatocele |
|
Phenol |
5.29 | 18646496 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
3.94 | 15862959 16503802 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
4.41 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
4.41 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
4.41 | 17575124 12958204 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
4.41 | 17261132 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.19 | 16321402 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.56 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
24.71 | 1399818 7505956 3712494 6587162 6582329 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
24.71 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
24.71 | 16010429 17909728 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
24.71 | 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
24.71 | 16026305 17045167 |
MESH:D013964 |
Thyroid Neoplasms |
|
triadimefon |
24.71 | 17178689 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
8.93 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
8.93 | 16051514 |
MESH:D014277 |
Trigeminal Neuralgia |
|
Phenol |
6.10 | 16527771 10223447 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.02 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
14.31 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
14.31 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
14.31 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
14.31 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
14.31 | 17653716 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
10.85 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
10.85 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.67 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
8.56 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
8.56 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
3.81 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.26 | 16752155 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.25 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
9.23 | 17334414 17638931 17678736 16364871 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
9.23 | 17488730 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.73 | 16761959 |
MESH:D014860 |
Warts |
|
Phenol |
5.75 | 19122958 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.90 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.45 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.68 | 16287080 |